VANI vs. NVRO, TCMD, SKIN, NYXH, DRTS, ELMD, RCEL, CATX, INGN, and LAKE
Should you be buying Vivani Medical stock or one of its competitors? The main competitors of Vivani Medical include Nevro (NVRO), Tactile Systems Technology (TCMD), Beauty Health (SKIN), Nyxoah (NYXH), Alpha Tau Medical (DRTS), Electromed (ELMD), AVITA Medical (RCEL), Perspective Therapeutics (CATX), Inogen (INGN), and Lakeland Industries (LAKE). These companies are all part of the "medical equipment" industry.
Vivani Medical vs.
Vivani Medical (NASDAQ:VANI) and Nevro (NYSE:NVRO) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, media sentiment, institutional ownership, valuation, dividends, analyst recommendations, earnings, profitability and community ranking.
Vivani Medical has a beta of 2.81, indicating that its stock price is 181% more volatile than the S&P 500. Comparatively, Nevro has a beta of 0.81, indicating that its stock price is 19% less volatile than the S&P 500.
Vivani Medical currently has a consensus price target of $4.00, indicating a potential upside of 250.88%. Nevro has a consensus price target of $5.36, indicating a potential downside of 8.29%. Given Vivani Medical's stronger consensus rating and higher possible upside, equities analysts plainly believe Vivani Medical is more favorable than Nevro.
In the previous week, Vivani Medical had 7 more articles in the media than Nevro. MarketBeat recorded 8 mentions for Vivani Medical and 1 mentions for Nevro. Vivani Medical's average media sentiment score of 0.26 beat Nevro's score of 0.00 indicating that Vivani Medical is being referred to more favorably in the media.
Vivani Medical has higher earnings, but lower revenue than Nevro. Vivani Medical is trading at a lower price-to-earnings ratio than Nevro, indicating that it is currently the more affordable of the two stocks.
Nevro received 497 more outperform votes than Vivani Medical when rated by MarketBeat users. However, 100.00% of users gave Vivani Medical an outperform vote while only 62.07% of users gave Nevro an outperform vote.
Vivani Medical has a net margin of 0.00% compared to Nevro's net margin of -16.54%. Nevro's return on equity of -23.52% beat Vivani Medical's return on equity.
6.8% of Vivani Medical shares are held by institutional investors. Comparatively, 95.5% of Nevro shares are held by institutional investors. 46.4% of Vivani Medical shares are held by company insiders. Comparatively, 3.2% of Nevro shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
Summary
Vivani Medical beats Nevro on 11 of the 16 factors compared between the two stocks.
Get Vivani Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for VANI and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Vivani Medical Competitors List
Related Companies and Tools
This page (NASDAQ:VANI) was last updated on 5/21/2025 by MarketBeat.com Staff
Buy VANI Stock Free VANI Stock Alerts